M&A Deal Summary |
|
|---|---|
| Date | 2014-04-17 |
| Target | Scientific Protein Laboratories |
| Sector | Life Science |
| Buyer(s) | Shenzhen Hepalink Pharmaceutical Group |
| Sellers(s) | American Capital |
| Deal Type | Add-on Acquisition |
| Deal Value | 338M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 2,046 |
| Revenue | 6.4B CNY (2021) |
Shenzhen Hepalink Pharmaceutical Group has been a leading global supplier of high quality active pharmaceutical ingredients (APIs) for nearly four decades. SPL specializes in cGMP biopharmaceutical manufacturing and is one of the largest commercial suppliers of Heparin Sodium USP, Pancreatin USP, and Pancrelipase USP. SPL serves the pharmaceutical, veterinary, and food industries globally, and has a manufacturing facility located in Waunakee, Wisconsin as well as a facility in Sioux City, Iowa. Shenzhen Hepalink Pharmaceutical Group was founded in 1998 and is based in Shenzhen, China.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Life Science) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 2 |
| State (Wisconsin) | 1 of 1 |
| Country (United States) | 1 of 2 |
| Year (2014) | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-08-24 |
Cytovance Biologics
Oklahoma City, Oklahoma, United States Cytovance is a contract manufacturing organization of mammalian and microbial biologics. The company works with biotechnology and pharmaceutical companies in the development and manufacturing of proteins, antibodies, and cell-based therapeutic products. Cytovance supports its customers from clinical development to commercial launch in domestic and international markets. |
Buy | $206M |
| Category | Private Equity Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 22.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
American Capital was a publicly traded buyout and mezzanine investment firm. American Capital invested in buyouts, growth capital financings, acquistion financings, and recapitalizations. The Firm looked to finance businesses with at least $4 million in EBITDA and valued between $20 and $500 million. American Capital ws a generalist firm with broad interest in traditional industries such as manufacturing, distribution, and services. American Capital's European investment affiliate is European Capital. European Capital looked to invest $10 to $600 million of equity, mezzanine, and/or senior debt in similar opportunities across Europe. American Capital was formed in 1997 and in January 2017, merged with Ares Capital Management.
| DEAL STATS | # |
|---|---|
| Overall | 155 of 194 |
| Sector (Life Science) | 5 of 6 |
| Type (Add-on Acquisition) | 76 of 87 |
| State (Wisconsin) | 5 of 7 |
| Country (United States) | 151 of 186 |
| Year (2014) | 5 of 13 |
| Size (of disclosed) | 23 of 56 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-04-16 |
Air Distribution Technologies
Richardson, Texas, United States Air Distribution Technologies is a provider of air-distribution and ventilation products for residential and industrial buildings in North America, with brands such as Ruskin, Titus, Hart & Cooley and Krueger. |
Sell | $1.6B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-10 |
Tensar
Alpharetta, Georgia, United States Tensar is a global provider of innovative subgrade soil reinforcement solutions, selling into more than 80 national markets through its two major product lines: Tensar geogrids and Geopier foundation systems. Geogrids are polymer-based products used for ground stabilization, soil reinforcement, and asphalt optimization in construction applications including roadways, public infrastructure, and industrial facilities. Tensar originated geogrid technology, which reduces aggregate consumption, thereby decreasing construction time, expense, and the project owner's cost of lifetime maintenance. The company also has a large portfolio of proprietary products. Tensar was formed in 1983 and is based in Alpharetta, Georgia. |
Sell | $400M |
